Dov Goldstein M.D.
Dov Goldstein, MD has served as a member of our board of directors since April 2008. He has been a partner at Aisling Capital, a private investment firm, since 2008. From 2006 to 2008, Dov was a Principal at Aisling Capital. From 2003 to 2005, Dov was Chief Financial Officer of Vicuron Pharmaceuticals, Inc. until its acquisition by Pfizer. Prior to that, Dov was an Executive Vice President of Vicuron Pharmaceuticals, Inc. Previously, he was Director of Venture Analysis at HealthCare Ventures. Dov is a director of a number of companies including ADMA Biologics, Inc. and Cempra Pharmaceuticals, Inc. (NASDAQ: CEMP). Dov earned a BS in biology from Stanford University, an MD from the Yale School of Medicine and an MBA from the Columbia Business School.